Allied Market Research recently published a report, titled, "Nuclear Medicine Equipment Market by Product (Single-Photon Emission Com ...

A Registrational Phase 2 clinical trial has been initiated in Japan for patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC). BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- ...

As 2026 begins, we are updating investors on Lantheus Holdings, Inc. (NASDAQ:LNTH), highlighting several recent developments. These include a summary of the poster presented at December’s Clinical ...

Lantheus (LNTH) Holdings completed the previously announced sale of its single photon emission computed tomography business to SHINE Technologies. Under the terms of the agreement, SHINE has acquired ...

BEDFORD, Mass. - Lantheus Holdings, Inc. (NASDAQ:LNTH), a $4.4 billion market cap radiopharmaceutical company, has finalized the previously announced divestiture of its single photon emission computed ...

BEDFORD, Mass., Jan. 02, 2026 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company dedicated to helping clinicians ...

SHINE acquires Billerica manufacturing facility and established SPECT product portfolio, expanding leadership in nuclear medicine JANESVILLE, Wis., Jan. 2, 2026 /PRNewswire/ -- SHINE announced today ...

Senior Research Fellow, The Perron Institute for Neurological and Translational Science, and Research Fellow, Faculty of Health Sciences, Curtin University A recent episode of the The Kardashians ...

The first official release of the 2025-26 men's college basketball NET rankings, a ranking system utilized as a sorting tool for NCAA Tournament selection committee that factors in winning percentage, ...